Part 2080 - ELECTRONIC PRESCRIPTION MONITORING PROGRAM
- Section 2080.10 - Authority
- Section 2080.20 - Incorporation by Reference and Definitions
- Section 2080.30 - General Description
- Section 2080.40 - Official Triplicate Prescription Blanks (Repealed)
- Section 2080.50 - Authorized Prescribers
- Section 2080.60 - Application (Repealed)
- Section 2080.70 - Schedule II-V Drug Prescription Requirements
- Section 2080.80 - Prohibited use of the Official Triplicate Prescription Blank (Repealed)
- Section 2080.90 - Dispensing a Schedule II, III, IV or V Drug
- Section 2080.100 - Dispenser Responsibility
- Section 2080.110 - Partial filling of prescriptions (Repealed)
- Section 2080.120 - Emergency situations (Repealed)
- Section 2080.130 - Prescriptions from out-of-state prescribers and exempt Federal practitioners (Repealed)
- Section 2080.140 - Exemption for prescribers in hospitals and institutions (Repealed)
- Section 2080.150 - Exemptions for long term care and home infusion services (Repealed)
- Section 2080.160 - Exemptions for narcotic treatment programs (Repealed)
- Section 2080.170 - Exemptions for research (Repealed)
- Section 2080.180 - Investigatory and regulatory referrals (Repealed)
- Section 2080.190 - Reports
- Section 2080.200 - Prescriber and Dispenser Inquiry System
- Section 2080.203 - Registering with the ILPMP
- Section 2080.205 - Accessing the ILPMP
- Section 2080.207 - EHR Integration with the ILPMP
- Section 2080.208 - Pharmacy Management Systems Integration with the ILPMP
- Section 2080.210 - Access to the Prescription Information Library (PIL) (Repealed)
- Section 2080.211 - Other State Prescription Monitoring Authority Access
- Section 2080.220 - Error Reporting
- Section 2080.230 - Designated Controlled Substances and Other Selected Drugs
- Section 2080.240 - Mid-Level Practitioners Prescriptive Authority Reporting
- Section 2080.245 - Advanced Practice Registered Nurse with Full Practice Authority
- Section 2080.250 - Mailing of Controlled Substances
- Section 2080.320 - Illinois Prescription Monitoring Program Advisory Committee (ILPMPAC)
- Section 2080.325 - Peer Review Committee